HotSpot Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch HotSpot Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody (NCT05662397) | HotSpot Therapeutics, Inc | 2023-03-15 |
Track HotSpot Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.